Judicial Decisions Regarding Expert Evidence on Violence Risk Assessment

In Canada, there are legal provisions called Dangerous Offender and Long-Term Offender designations available to apply severe restrictions on individual liberties for persons who engage in serious offences (often repetitive) and who pose a substantial risk for violence. Since establishing the presence of a risk for violence is central to decision making in these cases, an evaluator’s violence risk assessment (VRA) and expert witness testimony play a vital role in hearings for these offenders. The present study examined judicial decisions regarding expert evidence on VRAs submitted to the court in 214 Dangerous Offender/Long-Term Offender hearings identified through the Canadian Legal Information Institute database. Written judicial decisions were analysed for any comments regarding factors related to expert evidence on VRA. The commonalities that were identified, including qualities of: (1) the evaluators, (2) the VRAs completed, and (3) the evaluators’ expert testimony about VRA, offer key considerations for professionals working in the mental health and criminal justice fields. They may also contribute to the development of guidelines for professionals conducting VRA used by courts

A Conceptual Framework for Thinking About Physician-Assisted Death for Persons With a Mental Disorder

Physician-assisted death (PAD) has been enacted in a number of international jurisdictions, with several extending access to PAD for persons whose condition is not terminal, including those with a mental disorder.  We argue that based on the state of the literature, it is too early to make well-defined recommendations on how relevant fields can proceed legally, ethically, and clinically, particularly in regard to PAD for persons with a mental disorder.  The aim of this paper is to introduce a framework for further discussions on PAD for persons with a mental disorder to stimulate thoughtful and considered debate in our field.  We provide a brief discussion of the principles that guide regulatory frameworks on PAD practices worldwide, including a discussion of jurisdictions in Europe and North America that allow PAD for those suffering from an incurable non-terminal disease, illness, or disability.  Next, we present a conceptual framework as a series of questions that address legal, ethical, and clinical dilemmas arising from this trend.  We conclude with a summary of guidelines on the practice of PAD from international jurisdictions in order to assist in the development of potential legal and professional regulations

The Consideration of Indigenous Peoples in High Stakes Evaluations of Risk

While Indigenous peoples account for a small portion of the Canadian population, they are overrepresented in the Canadian Criminal Justice System. Research and case law suggest culture should always be considered in violence risk assessments (VRAs), but it is unknown whether this recommendation is followed. The present study examined the role of Indigenous versus non-Indigenous culture in judicial opinions regarding evaluators’ VRA and expert witness testimony in Dangerous Offender and Long-Term Offender (DO/LTO) hearings under Canadian Law. 214 DO/LTO hearings from 2009-2016 where judges commented on VRAs submitted to the court were systematically identified via the Canadian Legal Information Institute database. Judicial comments were analyzed in cases with Indigenous and non-Indigenous defendants for discussions of culture and the prevalence of comments regarding qualities of the evaluator(s), qualities of the VRA(s) completed, and qualities ofthe evaluators’ expert testimony about the VRA. Judges considered culture meaningfully in 64% of Indigenous offenders’ cases. Discussion of VRA tools’ content was significantly more frequent in non-Indigenous cases; otherwise, frequency of non-cultural themes did not vary between case groups. Given the importance of considering culture in VRA, it is concerning that culture was considered in just over half of cases; improving this deficit is discussed

New revelations about unemployment persistence in Spain: time-series and panel data approaches using regional data

This article aims to re-examine the persistence of unemployment in Spain. For this purpose, we use time-series and cross-section analysis. From a time-series viewpoint we disaggregate unemployment by regions, and use unit root tests, AR coefficients and fractional differencing parameters as indicators of persistence. For the cross-section approach, we first estimate mean regressions of regional unemployment rates. Then, using a panel of 114 periods and 50 provinces, we estimate pooled, fixed and random effects models. Finally, following some recent developments, we implement several panel data unit root tests. Previous studies had already shown the strong persistence of Spanish unemployment. Our disaggregated analysis extends the finding to reveal that the persistence is greater in the most industrialized regions. The results also suggest that a structural break took place in 1994, implying a decline in the unemployment persistence since then.

2p15-p16.1 microdeletion syndrome: Molecular characterization and association of the OTX1 and XPO1 genes with autism spectrum disorders

Reports of unrelated individuals with autism spectrum disorder (ASD) and similar clinical features having overlapping de novo interstitial deletions at 2p15–p16.1 suggest that this region harbors a gene(s) important to the development of autism. We molecularly characterized two such deletions, selecting two genes in this region, exportin 1 (XPO1) and orthodenticle homolog 1 (OTX1) for association studies in three North American cohorts (Autism Spectrum Disorder – Canadian American Research Consortium (ASD–CARC), New York, and Autism Genetic Resource Exchange (AGRE)) and one Italian cohort (Societa` Italiana per la Ricerca e la Formazione sull’Autismo (SIRFA)) of families with ASD. In XPO1, rs6735330 was associated with autism in all four cohorts (Po0.05), being significant in ASD–CARC cohorts (P-value following false discovery rate correction for multiple testing (PFDR)¼1.29105), the AGRE cohort (PFDR¼0.0011) and the combined families (PFDR¼2.34109). Similarly, in OTX1, rs2018650 and rs13000344 were associated with autism in ASD–CARC cohorts (PFDR¼8.65107 and 6.07105, respectively), AGRE cohort (PFDR¼0.0034 and 0.015, respectively) and the combined families (PFDR¼2.34109 and 0.00017, respectively); associations were marginal or insignificant in the New York and SIRFA cohorts. A significant association (PFDR¼2.631011) was found for the rs2018650G–rs13000344C haplotype. The above three SNPs were associated with severity of social interaction and verbal communication deficits and repetitive behaviors (P-values o0.01). No additional deletions were identified following screening of 798 ASD individuals. Our results indicate that deletion 2p15–p16.1 is not commonly associated with idiopathic ASD, but represents a novel contiguous gene syndrome associated with a constellation of phenotypic features (autism, intellectual disability, craniofacial/CNS dysmorphology), and that XPO1 and OXT1 may contribute to ASD in 2p15–p16.1 deletion cases and non-deletion cases of ASD mapping to this chromosome region